Login / Signup

Assessing the concurrent validity of days alive and at home metric.

Ernest ShenEmily J RozemaEric C HauptMaureen HenrySarah H ScholleSusan E WangJoanne LynnRichard A MularskiHuong Q Nguyennull null
Published in: Journal of the American Geriatrics Society (2021)
DAH measures are associated, albeit weakly, with clinically important improvement or maintenance of patient symptom burden in a diverse, seriously ill population.
Keyphrases
  • case report
  • locally advanced
  • risk factors
  • squamous cell carcinoma
  • patient reported